Disease/Infection News

RSS

Study reveals surprising gaps in some HIV medical providers' knowledge of ACA

A new study has revealed surprising gaps in some HIV medical providers' knowledge of the Affordable Care Act, with more than a quarter of providers surveyed unable to say whether their state had expanded Medicaid.

21 Sep 2018

Study highlights need to remain vigilant in maintaining key infection control processes

Healthcare-associated infections can be reduced by up to 55 percent by systematically implementing evidence-based infection prevention and control strategies, according to a review of 144 studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

21 Sep 2018

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

A naturally occurring antibiotic called kanglemycin A is effective against Mycobacterium tuberculosis, the bacteria that cause tuberculosis, even in drug-resistant strains, according to an international team of researchers who used chemistry, molecular biology, microbiology, and X-ray crystallography to show how the compound maintains its activity.

21 Sep 2018

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

An international research team, led by scientists from the German Primate Center, the Robert Koch Institute, the Max Planck Institute for Evolutionary Anthropology, McGill University, Masaryk University, the University of Tübingen and the Max Planck Institute for the Science of Human History, has successfully recovered genomes of the bacterium Treponema pallidum, which causes syphilis and yaws in humans, from wild nonhuman primate populations across sub-Saharan Africa.

20 Sep 2018

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

A clinical trial testing infusions of combination antibodies in people living with HIV has begun at the National Institutes of Health.

20 Sep 2018

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

A team of researchers at the University of Cologne's Faculty of Medicine and the German Center for Infection Research has achieved a scientific breakthrough in the accelerated diagnosis of multi-resistant hospital pathogens.

20 Sep 2018

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug with the help of chemotherapy medicines, according to new research published in the journal Nature Communications.

20 Sep 2018

Innovative approach for developing vaccine against most prevalent human malaria parasite

A novel study indicates promising avenues in an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa.

20 Sep 2018

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Pfizer Inc. announced today that its 20-Valent Pneumococcal Conjugate Vaccine candidate, PF-06482077, received Breakthrough Therapy designation from the US Food and Drug Administration for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae serotypes in the vaccine in adults aged 18 years and older. Pfizer expects to start Phase 3 trials in a few months.

20 Sep 2018

Rice seeds could hold key to preventing HIV infections

As incredible as it sounds, a rice paddy field could one day yield an inexpensive way to prevent HIV.

20 Sep 2018

Study could allow doctors to screen patients at risk from Aspergillus

Scientists at The University of Manchester have discovered a genetic mutation in humans linked to a 17-fold increase in the amount of dangerous fungal spores in the lungs.

20 Sep 2018

New platform examines infectious pathogens that may spread from animals to humans

Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.

20 Sep 2018

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces that it has signed a Memorandum of Understanding with Brazil-based Oswaldo Cruz Foundation 'Fiocruz' for the development of viral vaccines.

20 Sep 2018

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Vax-Hub, a new Future Vaccine Manufacturing Research Hub, will bring together academia, industry and policy makers to affect radical change in the development and manufacturing of vaccines and improve responses to outbreaks of deadly pandemics such as Swine Flu and Ebola.

20 Sep 2018

Scientists better understand influenza virus and how it spreads

The seasonal flu is caused by different subtypes of Influenza A virus and typically leads to the death of half a million people each year.

20 Sep 2018

Health care companies' data could enable more accurate flu season forecasts

In an era when for-profit companies collect a wealth of data about us, new research from The University of Texas at Austin shows that data collected by health care companies could -- if made available to researchers and public health agencies -- enable more accurate forecasts of when the next flu season will peak, how long it will last and how many people will get sick.

20 Sep 2018

Detection of BFD virus in parrots in 8 new countries raises concerns for threatened species

Beak and feather disease virus in wild parrot populations has been detected in eight new countries, raising concerns for threatened species.

20 Sep 2018

LSTM partners with TB Alliance to develop novel TB drug regimens

LSTM and TB Alliance are collaborating to investigate novel combination drug therapies that could help the fight against multidrug-resistant tuberculosis (MDR-TB), following an award of £1 million from the Medical Research Council.

19 Sep 2018

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that the company has received positive feedback, via written response, from the U.S. Food and Drug Administration regarding its development plans for AB-PA01, without the need for a Type B Pre-IND meeting.

19 Sep 2018

UTILITY receives FDA approval for Investigational New Drug applications

UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.

19 Sep 2018

Disease/Infection News

Study reveals surprising gaps in some HIV medical providers' knowledge of ACA

Study highlights need to remain vigilant in maintaining key infection control processes

New naturally occurring antibiotic found effective against Mycobacterium tuberculosis

Scientists find wild African monkeys infected with bacterium that causes syphilis, yaws in humans

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

Scientists achieve breakthrough in accelerated diagnosis of multi-resistant hospital pathogens

Scientists find way to boost efficacy of powerful antimalarial drug with anti-cancer medicines

Innovative approach for developing vaccine against most prevalent human malaria parasite

Pfizer’s 20vPnC vaccine receives Breakthrough Therapy designation from FDA

Rice seeds could hold key to preventing HIV infections

Study could allow doctors to screen patients at risk from Aspergillus

New platform examines infectious pathogens that may spread from animals to humans

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Vax-Hub to influenze radical change in development and manufacturing of vaccines

Scientists better understand influenza virus and how it spreads

Health care companies' data could enable more accurate flu season forecasts

Detection of BFD virus in parrots in 8 new countries raises concerns for threatened species

LSTM partners with TB Alliance to develop novel TB drug regimens

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

UTILITY receives FDA approval for Investigational New Drug applications

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News